Our weight loss projections are grounded in data from the largest and most rigorous clinical trials conducted on GLP-1 medications: Published in the New England Journal of Medicine in 2021, the STEP-1 trial enrolled 1,961 adults with overweight or obesity
Another 14 percent attended structured lifestyle modification visits with dietitians, exercise specialists, or other health professionals
Whats in the plan Built for GLP-1 Success Created specifically with GLP-1 users in mind, this plan supports critical nutrient targetsespecially protein, fiber, and hydrationwhile helping manage common medication-related challenges like appetite changes and digestive shifts
Injectable B12 may deliver better results because: Direct bloodstream access bypasses digestive absorption barriers Higher bioavailability allows for less frequent dosing Consistent therapeutic levels maintain steady benefits [6] Disclaimer: The FDA does not approve compounded medications for safety, quality, or manufacturing
In turn, this makes you feel fuller for longer, leading to less intake of calories
after 30 days, the dose may be increased to 7 mg once daily